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Purpose: The aim of this study was to longitudinally assess the prevalence of allergic sensitiza-
tion, asthma, eczema and hay fever from infancy to adulthood in a single cohort.
Participants and methods: This prospective study is based on a longitudinal birth cohort of 
253 participants, with respiratory and immunological assessments at 1, 6, 11, 18 and 24 years 
of age. Subjects were recruited from an urban maternity hospital. Retention rates varied from 
45% to 72% at follow-up assessments. Asthma diagnosis was based on physician diagnosis of 
asthma and symptoms/medications in the previous 12 months. Allergic sensitization was defined 
by the positive skin prick test. Hay fever and eczema were based on a questionnaire.
Results: The prevalence of allergic sensitization rose from 19% (n=33) at 1 year of age to 71% 
(n=77) at 24 years of age. The rate of asthma halved from 25% at 6 years of age to 12%–15% 
between 11 and 24 years of age, but the prevalence of allergic sensitization among those with 
asthma doubled from 50% at 6 years of age to 100% at 24 years of age. Hay fever rates rose 
throughout childhood from 7% at 6 years of age to 44% at 24 years of age, while the preva-
lence of eczema reduced from 25% at 6 years of age to 16% at 24 years of age. Parental atopy 
doubled the odds of asthma in their offspring by 24 years of age (odds ratio [OR]= 2.63, 95% CI 
1.1–6.2, p=0.029). In all, 74% of those with asthma at 24 years of age also reported hay fever. 
The relationship between eczema and asthma was only significant up to 11 years of age, and 
the relationship between hay fever and asthma was stronger in adolescence and early adulthood 
than in early childhood.
Conclusion: Patterns of atopic disorders vary throughout childhood. Although the prevalence 
of allergic sensitization and hay fever rose throughout childhood and the prevalence of asthma 
reduced, the strength of their relationship with asthma increased with age.
Keywords: allergy, rhinitis, childhood, adolescence
Plain language summary
What was known before this study?
Asthma is linked to conditions such as allergies, eczema and hay fever and prevalence rates 
are very high in Australia.
Why did we do this study?
We measureed allergy responses in a group of people every 5-6 years, from infancy to early 
adulthood to seehow the rates of asthma, allergy, eczema and hay fever change with age, and 
how the diagnoses of asthma, allergy, hay fever and eczema relate to or predict each other.
What did we find?
•  A higher proportion had asthma and eczema during early childhood (up to 6 years of age) 
than when older (from 11 to 24 years).
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•  Hayfever and allergies were more common in early adulthood 
than early childhood
•  Eczema was closely linked to asthma in early childhood, but not 
in late teens.
•  The link between hay fever and asthma was weaker during early 
childhood than during adolescence.
•  Having a parent with asthma or allergy doubled the risk of their 
child having asthma.
What does this mean?
Allergies and hay fever are very common among adolescents with
asthma. Eczema should not be used as a predictor for
asthma in older children.
Introduction
Atopy, a genetic susceptibility to developing allergic dis-
orders, is commonly associated with asthma in children. 
The prevalence of atopy is higher among children with 
asthma at 40%–77% compared with 21%–64% of children 
without asthma.1 Other atopic disorders such as eczema and 
allergic rhinitis are also common comorbidities for children 
with asthma, referred to as “allergic multimorbidity”.2,3 In 
unsupervised cluster analysis, performed to characterize 
sub-phenotype groups of asthma, atopy is more common 
in all asthma clusters than in non-asthmatics. Yet, it is not 
a defining feature of any group, as there are those with and 
without atopy in all clusters.4
Individuals who are atopic have a tendency to develop 
IgE sensitization to environmental triggers (allergens). 
These can include house dust mites, pollens, moulds or 
foods. Measurement of these hyper-IgE reactions is used 
to assess for atopy. Allergic sensitization in childhood is 
a predictive factor for the development of asthma later 
on. This link is strongest for those who develop allergic 
sensitization within the first few years of life.5,6 However, 
a recent study from our group showed that early onset 
sensitization was predictive of asthma only up to 6 years 
of age, and there was no significant link with asthma from 
11 to 24 years of age.7
Given the prevalence of atopy in asthma, as well as the 
predictive strength of early sensitization for a subsequent 
diagnosis of asthma, allergic sensitization has been hypoth-
esized to play a causal role in the development of asthma, 
 possibly with allergen-induced airway inflammation interact-
ing with the airway microbiome and viral respiratory infec-
tions to create a chronic asthmatic phenotype.6,8 However, 
comparison of the prevalence rates of allergic sensitization 
and asthma in population groups suggests that they do 
not closely correlate with each other, whether looking at 
 worldwide populations or even between states in Australia, 
as would be expected if the relationship was causal.1,9,10 Areas 
with the highest rates of allergic sensitization do not have 
the highest rates of asthma. When the prevalence rates of 
sensitization and asthma throughout childhood are assessed, 
allergic sensitization appears to increase through infancy, 
school age, adolescence and early adulthood, whereas 
asthma prevalence peaks before 10 years of age and again 
in adulthood with a trough in between these periods.11–14 
Therefore, our aims were to assess the longitudinal preva-
lence of asthma, allergic sensitization and related conditions 
of eczema and hay fever from infancy to early adulthood 
in a single cohort using data from the Perth Infant Asthma 
Follow-up (PIAF) study and to assess the trending of each 
disorder in relation to each other.
Participants and methods
The PIAF study involves a longitudinal birth cohort of 253 
infants recruited between 1987 and 1989 from a general 
antenatal clinic in Perth, Western Australia. Recruitment 
has been described previously.15 Families were not selected 
based on risk factors for atopy or asthma. However, there 
was a higher prevalence of parental allergic rhinitis and 
eczema, but not asthma, among those who enrolled com-
pared with those who declined. Infants were excluded if 
they had <37 weeks of gestation at birth or if they had a 
respiratory illness prior to their first assessment at 1 month. 
Comprehensive respiratory and immunological assessments 
were carried out at 1, 6 and 12 months in those aged 6, 11, 
18 and 24 years. Each assessment included a questionnaire 
and skin prick testing, with total and specific IgE testing 
added from 18 years onward.
Skin prick testing to five allergens was carried out at each 
of the infant assessments up to 1 year (rye grass pollen, cow’s 
milk, egg white, Dermatophagoides pteronyssinus and Der-
matophagoides farinae).16 A further six allergens were added 
from 6 years onward (mixed grass, cat pellet, dog dander, 
cockroach, Alternaria tenuis and Aspergillus fumigatus). A 
wheal with a diameter of at least 3 × 3 mm greater than the 
negative control was considered as positive.
Specific IgE testing to house dust mite, cat and a mixed 
grass consisting of Bermuda, rye, Timothy, meadow (Ken-
tucky blue), Johnson and Bahia grasses was performed using 
ImmunoCAP in those aged 18 and 24 years. A standard cutoff 
value of 0.35 iU/mL was used. Allergic sensitization was 
defined by at least one positive allergen on the skin prick 
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test or any specific IgE of >0.35 iU/mL, as specified in the 
results. Only skin prick testing was used in the longitudinal 
prevalence data of allergic sensitization, given that it had 
been measured at all assessments.
“Current asthma” was defined by a physician diag-
nosis of asthma with symptoms or medications within 
the previous 12 months. Questions relating to allergies 
included do you have hay fever? (yes/no), have you ever 
been diagnosed with eczema? (yes/no) and do you still 
have eczema? (yes/no).
Each assessment was authorized by the ethics com-
mittee of Western Australia Child and Adolescent Health 
Service Research. Written informed consent was obtained 
for each assessment from either the parent (if the partici-
pant was <18 years of age at the time of assessment) or 
the subject themselves (if the participant was >18 years 
of age), as approved by the ethics committee of Western 
Australia Child and Adolescent Health Service Research 
(HREC 2054EP).
Statistics
Differences in prevalence rates between groups were 
compared using Pearson’s chi-square test for categorical 
variables and Student’s t-test for continuous variables. Con-
temporaneous prevalence rates for asthma, eczema, allergic 
sensitization and hay fever were based only on those seen 
at the assessment.
The predictive strength of factors for a diagnosis of 
asthma at each assessment was measured using logistic 
regression, and odds ratios (ORs) were reported. Spear-
man’s correlation was used to assess the link between 
current asthma and allergic sensitization at 24 years of 
age. Only those with data recorded for both parents were 
included in the analysis of parental history. The correla-
tion between skin prick test results and specific IgE tests 
was assessed using Pearson’s correlation coefficient and 
chi-square test.
A two-sided p value of <0.05 was used to define statistical 
significance. Statistical analyses were performed using IBM 
SPSS Statistics for Windows, version 20.0 (released 2011; 
IBM Corporation, Armonk, NY, USA).
Results
Population demographics
Follow-up rates at each assessment varied from 45% to 72%, 
with 77 subjects (30%) seen in all four assessments at 6, 11, 
18 and 24 years. Characteristics and demographics of those 
seen at each assessment have been published previously.7 The 
proportion of subjects with atopic sensitization by 1 year of 
age was significantly higher in the group seen at 24 years 
(25%) than the whole cohort (19%).
Prevalence of atopy and asthma
The prevalence of allergic sensitization, based on the skin 
prick test, rose from 19% (n=33) by 1 year of age to 71% 
(n=77) at 24 years of age (Figure 1). The prevalence of hay 
fever also increased rapidly throughout childhood, rising from 
7% (n=8) at 6 years of age to 44% (n=64) at 24 years of age. 
The prevalence of current asthma peaked at 6 years of age at 
25% (n=32), followed by a steady rate of 11%–15% between 
11 and 24 years of age. Eczema prevalence halved between 1 
and 11 years of age. There was no significant sex difference 
in the prevalence of asthma, allergic sensitization, hay fever 
or eczema at any assessment.
Figure 1 Percent prevalence of allergic sensitization, hay fever, eczema, and asthma at each assessment.
Notes: Allergic sensitization is based on the positive skin prick test. Current asthma at each assessment (physician diagnosis with symptoms or medications within the 
previous 12 months) is shown.
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Specific IgE testing correlated strongly with skin prick 
testing, with a coefficient of 0.63 (p<0.001) at 18 years of 
age and 0.7 at 24 years of age (p<0.001). A positive specific 
IgE test had a 97% sensitivity and 66% specificity at 18 years 
of age and 88% sensitivity and 75% specificity at 24 years 
of age for the positive skin prick test.
Family history and asthma
Of the 242 subjects with data collected from both parents, 
31% (n=75) had a parent with asthma, which doubled the risk 
of asthma by 24 years of age in their offspring (OR=2.35, 
95% CI 1.1–5, p=0.027). Two-thirds of the subjects (66%, 
n=160) had a parent with eczema, asthma or allergic rhinitis, 
which was associated with a similar increased risk of asthma 
by 24 years (OR=2.63, 95% CI 1.1–6.2, p=0.029).
Prevalence of allergic sensitization and 
multimorbidity in asthma
Only 50% of those with asthma had a positive skin prick test 
at 6 years of age, but this doubled to 100% by 24 years. The 
prevalence of hay fever among those with asthma rose from 
14% at 6 years of age to 74% by 24 years (Figure 2). The 
prevalence of eczema among children with asthma halved 
between 6 and 24 years of age. Less than one-quarter of those 
with asthma had both eczema and hay fever at any assess-
ment. All of those with asthma plus eczema at 24 years of age 
also had hay fever. Approximately 20% of those with allergic 
sensitization had asthma at each assessment between 11 and 
24 years of age (Figure 3).
The predictive strength of allergic sensitization, eczema 
and hay fever for asthma also varied with age (Table 1). At 
Figure 2 Percentage of subjects with asthma and other atopic traits at each assessment.
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Figure 3 Percentage of subjects with allergic sensitization who had asthma at each assessment.
Notes: Allergic sensitization based on a current positive skin prick test. Only current asthma (symptoms or medications within previous 12 months) is shown.
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6 years of age, allergic sensitization was associated with 
an increased risk of asthma, with a trend toward statistical 
significance (OR=2.3, p=0.056). At 24 years of age, as all of 
those with asthma also had allergic sensitization, an OR could 
not be calculated; however, the correlation was significant 
(spearman’s rho 0.258, p=0.008). At 6 years of age, eczema 
was strongly associated with asthma (OR=4.8, p=0.002), 
while hay fever was not significantly associated with asthma 
(OR=3.7, p=0.081). Eczema was no longer predictive of 
asthma at 18 or 24 years of age, while hay fever was signifi-
cantly associated with asthma from 11 to 24 years of age.
Prevalence of house dust mite and grass 
sensitization
House dust mite and mixed grass were the two most com-
mon allergens on skin prick testing at each assessment. 
House dust mite sensitization was slightly more prevalent 
at each assessment, and 40%–60% of those with house dust 
mite sensitization at each assessment were also sensitized to 
mixed grass (Figure 4).
Discussion
Asthma, eczema and hay fever have been described as “the 
atopic triad”.17 We have shown in a longitudinal birth cohort 
with data to early adulthood that the prevalence of allergic 
sensitization rapidly increases throughout childhood into 
early adulthood. However, the associated atopic disorders do 
not all share the same trajectory, with only hay fever follow-
ing a similar increase in prevalence into adulthood. This has 
important implications not only in understanding the natural 
history of atopy and atopic diseases but also for economic 
planning and disease prevention strategies.
Australia has one of the highest rates of atopy world-
wide with rates continuing to rise, and atopic disorders are 
accompanied by a significant burden on both patients and 
their health systems.18–20 Atopy is associated with inherited 
factors and environmental exposures; therefore, collecting 
up-to-date local epidemiological information is necessary. 
In a recent longitudinal Danish study, the rate of allergic 
sensitization in early adulthood was 31% at 26 years of age, 
less than half the rate in our Australian cohort, demonstrat-
ing the importance of collecting local data.21 Both our cohort 
and the Danish cohort reported a similar rapid increase in 
the prevalence of allergic rhinitis throughout childhood; 
however, the trends in asthma were not concordant. In the 
Danish cohort, asthma rates increased between 5 and 10 years 
of age up to a peak of 10%, whereas in our cohort, there was 
an asthma prevalence of 26% at 6 years of age, followed by a 
Table 1 Predictive strength of allergic sensitization, hay fever and eczema for asthma at each assessment
Asthma diagnosis at each 
assessment
Allergic sensitization OR 
(95% CI)
Hay fever OR (95% CI) Eczema OR (95% CI)
Asthma at 6 years of age (n=30) 2.3 (0.99–5.46), p=0.054 3.7 (0.85–15.75), p=0.081 4.8 (1.78–12.94), p=0.002
Asthma at 11 years of age (n=29) 3.4 (1.37–8.53), p=0.008 3.6 (1.51–8.54), p=0.004 6.1 (2.44–15.32), p<0.001
Asthma at 18 years of age (n=19) 4.5 (1.41–14.57), p=0.011 5.9 (2.7–16.67), p=0.001 2.8 (0.65–12.08), p=0.167
Asthma at 24 years of age (n=24) N/A, p=N/A 4.7 (1.73–12.76), p=0.002 1.4 (0.43–4.8), p=0.6
Notes: OR, odds ratio for having allergic sensitization, hay fever or eczema if asthma was diagnosed at each assessment. Allergic sensitization based on the positive skin 
prick test. Bold font indicates p<0.05.
Figure 4 Percentage of participants sensitized to mixed grass and house dust mite at each assessment.
Note: Sensitization was measured by the skin prick test, wheal ≥3×3 mm.
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reduction in later childhood. This early peak in asthma preva-
lence within our cohort is unlikely to be explained simply by 
the high rates of asthma in Australia, as by 11 years of age, 
asthma rates were very similar between the two cohorts but 
may be related to differing predominant asthma phenotypes 
in the two countries.
This longitudinal analysis also highlights some impor-
tant features of the relationships between different atopic 
disorders. There has been a long running debate regarding 
the role of atopy in asthma and whether this is causative 
or not.22 Viral respiratory infections and sensitization to 
aeroallergens within the first few years of life appear to have 
a synergistic effect on both the risk of asthma developing 
during childhood and the degree of airway inflammation 
during acute exacerbations.6,8,23,24 Many studies have looked 
at the efficacy of early allergen avoidance in the primary 
prevention of asthma with mixed results.25 In our study, 
although there was a strong association between asthma and 
allergic sensitization throughout childhood and into adult-
hood, the prevalence of positive skin prick tests rose from 
35% at 6 years of age to 71% at 24 years of age, while the 
prevalence of asthma dropped over the same time period. 
This inverse relationship is supported by previous cross-
sectional studies that demonstrated that rates of allergic 
sensitization and asthma do not correlate.9,10 This supports 
the theory that only early sensitization, within the first few 
years of life, could have a strong causative role in asthma 
development.
All of those with asthma at 24 years of age had a positive 
skin prick test compared with only 50% of those with asthma 
at 6 years of age. This may be reflective of the general increase 
in atopy prevalence, as the prevalence of asthma among those 
with allergic sensitization remained stable at 20% from 11 
to 24 years of age; however, asthma was strongly correlated 
with allergic sensitization at 24 years of age, suggesting a 
genuine relationship between the two.
In preschool children, eczema is one of only two major 
factors on the Asthma Predictive Index that helps to predict 
which young children with recurrent wheeze will develop 
asthma.26 Clinicians have been using this predictive tool for 
several decades when counseling parents about the risk of 
their child developing asthma.27 Children with eczema have 
also been chosen in asthma prevention studies due to their 
increased risk of developing asthma.28 However in our study, 
eczema was only associated with asthma up to 11 years of 
age; therefore, the absence of eczema should not be used 
as a clinical tool to distinguish asthma from other causes 
of respiratory symptoms in older children and adolescents.
We have demonstrated that a positive skin prick test has 
a much stronger relationship with asthma than eczema and 
indeed may make the diagnosis of asthma unlikely in older 
adolescents if negative. Previous studies have shown that 
multi-sensitivity is a stronger predictive tool for asthma than 
sensitivity to single allergens and in the UK MAAS study, 
several classes of atopy were identified and only early onset 
sensitization to multiple allergens was associated with an 
increased risk of asthma.29,30 Hay fever also has a strong 
relationship with asthma during adolescence in our cohort 
and may be useful as part of a clinical diagnostic tool, par-
ticularly in the absence of skin prick testing.
There is a long-standing belief in the developmental 
progression of allergic disorders from eczema in infancy to 
asthma in childhood and then allergic rhinitis in adolescence, 
with a resolution of the eczema over this period (the atopic 
march).31,32 This theory was recently disputed by a large study 
in the UK looking at the prevalence of eczema, asthma and 
hay fever in two pediatric longitudinal cohorts.33 Belgrave 
et al identified a number of atopic disease trajectories and 
demonstrated that the temporal relationships between atopic 
disorders are a lot more complex than previously believed. 
Less than 10% of their cohort followed the classical atopic 
march path. Unfortunately, our cohort was too small to 
assess the frequency of the atopic trajectories described in 
the UK study, but we did show that among those with asthma 
at 6 years of age, eczema was the most common allergic 
comorbidity and by 18 years, hay fever was the most com-
mon comorbidity.
Skin prick testing is often used in cohort studies as a wide 
range of allergens can be tested easily and cost-effectively; 
however, in practice, many allergy clinics use specific IgE. 
Unfortunately, the two methods do not correlate well in young 
children.34 We used both methods at 18 and 24 years of age 
and found that specific IgE testing had a very good sensitivity 
with moderate specificity for skin prick testing, likely related 
to the utilization of a much smaller allergen panel.
The prevalence of allergic sensitization at 24 years of 
age was higher than we expected for an unselected cohort 
at 71%; however, it was not dissimilar to the rate of 65% 
seen in the Dunedin birth cohort at 21 years of age.13 The 
increase in prevalence of atopy across childhood, which we 
observed, was likely due to a combination of factors. First, 
there has been an increase in atopy worldwide over the past 
few decades, and second, there is a documented increase in 
atopy during childhood and adolescence.12,13,35 In addition, 
two-thirds of the families enrolled in this study had at least 
one parent with a history of atopy and those participants 
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with early sensitization were less likely to withdraw from 
the 24-year follow-up. This may reflect some selection bias 
among those recruited and retained for long-term follow-up 
due to their increased interest in the study. Perth is the most 
isolated capital city in the world, and many young adults move 
interstate for travel, work or college, meaning they are unable 
to attend follow-up assessments. This likely contributed to 
our poor retention rates at some assessments.
One of the limitations of this study is that the definition 
of asthma was based on physician’s diagnosis. This did not 
take the complexity of different asthma phenotypes and their 
underlying pathophysiology into account.36 The pathogenesis 
of asthma is still not clearly understood with abnormal epithe-
lium, immature innate immune responses, genetics, abnormal 
lung development and the environment, all implicated.37–39 
Interestingly, some of the gene mutations linking asthma, 
eczema and hay fever are not related to immune responses 
but rather the integrity of the epithelium.40–41
Conclusion
This collection of serial data at crucial developmental periods 
during childhood and adolescence allows for a comprehen-
sive analysis of atopy trends in the first 3 decades of life. The 
longitudinal study of allergic sensitization, hay fever, eczema 
and asthma prevalence in an urban environment highlights that 
although rates of allergic sensitization and hay fever increase 
throughout childhood and into early adulthood and rates of 
asthma reduce, their relationship with asthma strengthens. 
Universal assumptions should not be made about the relation-
ships between atopic disorders as they may be age dependent.
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